Ensysce Biosciences, Inc. (ENSC) Q2 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ensysce Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:03.631 Good morning and welcome to the NCISE Biosciences, Inc. 00:00:03.631 -- 00:00:09.453 Corporate Update Call. As a reminder, this conference is being recorded. 00:00:09.534 -- 00:00:15.257 Your hosts today are Dr. Lynn Kirkpatrick, Chief Executive Officer, Dr. 00:00:15.257 -- 00:00:20.420 Nylee Osman, Chief Medical Officer, and Dave Humphrey, Chief Financial 00:00:20.420 -- 00:00:25.623 Officer. Before we begin the formal presentation, I would like to remind everyone that 00:00:25.623 -- 00:00:30.762 statements made on the call and webcast may include predictions, estimates, 00:00:30.762 -- 00:00:34.526 or other information that might be considered forward-looking. 00:00:34.526 -- 00:00:39.170 While these forward-looking statements represent our current judgment on what the future 00:00:39.170 -- 00:00:44.255 holds, they are subject to risks and uncertainties that could cause actual results 00:00:44.255 -- 00:00:46.157 to differ materially. 00:00:46.157 -- 00:00:50.801 You are cautioned not to place undue reliance on these forward-looking statements, which 00:00:50.801 -- 00:00:55.000 reflect our opinions only as of the date of this presentation. 00:00:55.000 -- 00:01:00.184 Please keep in mind that we are not obligating ourselves to revise or publicly release 00:01:00.184 -- 00:01:05.028 the results of any revision to these forward-looking statements in light of new information 00:01:05.028 -- 00:01:10.052 or future events. Throughout today's discussion, we will attempt to present some important 00:01:10.052 -- 00:01:14.035 factors relating to our business that may affect our predictions. 00:01:14.035 -- 00:01:19.219 You should also review our most recent forms, 10Q and 10K, for a more 00:01:19.219 -- 00:01:24.082 complete discussio...